Sponsors

Disinfectants and hand sanitisers: a new test of efficacy against viruses

Do hand sanitisers really work against viruses? Andrew Kemp and colleagues introduce a new methodology for testing the efficacy of disinfectants and sanitisers on surfaces and on the skin against viral isolates.

In light of the recent appearance of a novel coronavirus disease, COVID-19, into southern China, the authors adapted the Spearman-Kärber1,2 tissue culture infectious dose50 (TCID50) test method in order to test the efficacy of hand sanitisers and disinfectants over time on surfaces and on the skin.

It is important when using any disinfection chemistry both to know what it kills and for how long. It is clear from studies of bacterial contamination on hands and surfaces that the longer disinfectants and sanitisers remain active, the more effective they are at reducing the potential for cross-infection. As the coronavirus responsible for COVID-19 almost certainly is spread predominantly by droplets, disinfection of surfaces and sanitation of hands become of even greater importance to reducing its spread.

There are now two main categories of disinfectants and sanitisers commercially available,3–5 yet most test methodologies are only appropriate for one of them. It is relatively easy to differentiate between these two categories. The non-persistent chemistries (wet in use) and the persistent chemistries (dry in use) have significantly different instructions for use. The main practical difference is the longevity of antimicrobial activity. Once applied, how long does antimicrobial activity continue? In the case of alcohol, this may be as little as 35–60 seconds,6 and for chlorhexidine gluconate (CHG), up to around four hours on skin. On surfaces, it is a little more difficult to be accurate about the persistence of activity, as this will depend on concentration and the amount of fluid used, environmental temperature and humidity.7

Log in or register FREE to read the rest

This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text. If you don't already have an account, please register with us completely free of charge.

Latest Issues

RSM / Path Soc 2026 Winter Meeting

The Royal Society of Medicine, 1 Wimpole St, London, W1G 0AE
20 - 21 January, 2026

BIVDA Regulatory Affairs Seminar

Grand Hotel, Birmingham
10 - 11 February, 2026

BDIAP Molecular Pathology Study Day

10 Union Street, London, SE1 1SZ
2 March, 2026

USCAP 115th Annual Meeting

Henry B. González Convention Center, San Antonio, Texas, USA
21 - 26 March, 2026

Microbiology Society Annual Conference 2026

ICC Belfast, Northern Ireland
13 - 16 April, 2026